Livzon Pharmaceutical Group Inc. Company Information
Livzon Pharmaceutical Group Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: Livzon Pharmaceutical Group Inc.
- Ticker: 000513
- Exchange: SZSE
- Founded: 1985
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: CN¥30.431b
- Shares Outstanding: 906.93m
- Website: https://www.livzon.com.cn
Number of Employees
Location
- Livzon Pharmaceutical Group Inc.
- Headquarters Building
- No. 38 Chuangye North Road
- Zhuhai
- Guangdong Province
- 519090
- China
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 000513 | SZSE (Shenzhen Stock Exchange) | Yes | Domestic Shares | CN | CNY | Jun 1995 |
| 000513 | XSEC (Shenzhen Stock Exchange - Shenzhen-Hong Kong Stock Connect) | Yes | Domestic Shares | CN | CNY | Jun 1995 |
| 1513 | SEHK (The Stock Exchange of Hong Kong Ltd.) | Foreign Shares-Foreign Listed | HK | HKD | Jan 2014 | |
| LP6 | DB (Deutsche Boerse AG) | Foreign Shares-Foreign Listed | DE | EUR | Jan 2014 | |
| 1513 | SZSC (The Stock Exchange of Hong Kong - Shenzhen - Hong Kong Stock Connect) | Foreign Shares-Foreign Listed | HK | HKD | Jan 2014 | |
| LVZP.F | OTCPK (Pink Sheets LLC) | Foreign Shares-Foreign Listed | US | USD | Jan 2014 | |
| 1513 | SHSC (Stock Exchange of Hong Kong Limited - Shanghai - Hong Kong Stock Connect) | Foreign Shares-Foreign Listed | HK | HKD | Jan 2014 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 06:04 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 06:04 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Livzon Pharmaceutical Group Inc. is covered by 30 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ling Zhang | BNP Paribas Securities (Asia) |
| Helena Qiu | CCB International Securities Limited |
| Shuchang Liu | Changjiang Securities Co. LTD. |